PR: Atossa Genetics Inc (NASDAQ: ATOS) shares soared more than 40 percent Thursday after it signed an agreement with a major distributor for an upcoming launch of its FullCyte device used in breast examinations.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2015-02-26 11:22:23 | ATOS | buy | $2.330 | long |
2015-02-26 11:22:23 | ATOS | buy | $2.330 | long |
2015-02-26 11:22:23 | ATOS | buy | $2.330 | long |
2015-02-26 11:33:21 | ATOS | sell | $2.230 | long |
2015-02-26 11:33:21 | ATOS | sell | $2.230 | 0 |
2015-02-26 11:34:12 | ATOS | sell | $2.240 | short |
2015-02-26 11:34:12 | ATOS | sell | $2.240 | short |
2015-02-26 11:34:15 | ATOS | sell | $2.240 | short |
2015-02-26 11:43:00 | ATOS | buy | $2.310 | short |
2015-02-26 11:43:40 | ATOS | buy | $2.310 | 0 |
2015-02-26 11:45:22 | ATOS | buy | $2.330 | long |
2015-02-26 11:45:22 | ATOS | buy | $2.330 | long |
2015-02-26 11:45:22 | ATOS | buy | $2.330 | long |
2015-02-26 11:51:42 | ATOS | sell | $2.410 | long |
2015-02-26 11:58:56 | ATOS | sell | $2.315 | long |
2015-02-26 11:58:56 | ATOS | sell | $2.315 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!